Nlybrominated dibenzo-p-dioxins (PBDDs) and dibenzolurans (PBDFs) occur as trace (ppb) contaminantsin brominated flame retardants and are produced during combustion ofthese chemicals. They are also formed when organics are incinerated in the presence ofbromine, e. g., in municipal and industrial incinerators and in internal-combustion engines. Combustion of organics in the presence of both bromine and chlorine results in the formation of mixed (ie., bromo, bromo/chloro and chloro) halogenated dibenzo-p-dioxins and dibenzofurans (HDDs and HDFs 
Introduction
Relatively little is known about the environmental and toxicologic significance of polybrominated dibenzo-p-dioxins and dibenzofurans (PBDDs and PBDFs). These chemicals have only recently been identified as potential environmental pollutants. The chlorinated analogs ofthese chemicals have been studied for years.
Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) are recognized as relatively low-level but toxicologically significant environmental contaminants. These materials are not manufactured commercially, but some appear as impurities in certain products such as herbicides and fungicides. In addition, significant amounts of these important chemicals are produced in thermal reactions, such as those in municipal and industrial waste incineration, accidental fires, and the burning of automotive fuels that contain chlorinated additives. In fact, the generation of PCDDs and PCDFs is considered likely whenever organic materials and a suitable chlo-rine source are combusted under oxygen deficient conditions.
The experimental and clinical toxicology of the PCDDs and PCDFs have been extensively studied and well documented; therefore, they will not be extensively reviewed in this paper. The most potent PCDDs and PCDFs are the 2,3,7,8-chloro congeners, but all are considered to possess significant toxicologic potential (1) (2) (3) . Human exposures to PCDDs and PCDFs have been associated with dermal, hepatic, gastrointestinal, and possibly neurologic toxicity. Also, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been shown to be a potent carcinogen in laboratory rodents, and Fingerhut etal. (4) have reported an association between high cumulative doses and excess cancer mortality among occupationally exposed humans. PCDDs and PCDFs have also been shown to produce immunologic, reproductive, and developmental toxicities in laboratory animals.
There are only limited quantitative data regarding the environmental occurrence ofPBDDs and PBDFs, and it is impossible at this time to project the magnitude ofhealth hazard, if any, that may attend the accidental and/or incidental production of these compounds. However, their structural similarities to the PCDDs and PCDFs make them logical subjects for environmental and toxicologic investigation. The purpose ofthis communication is to present a preliminary review ofthe literature concerning the human health hazard potential of PBDDs and PBDFs.
Dibenzo-p-dioxin 9 1 Dibenzofuran 9 1 FIGURE 1. Structural formulas of unsubstituted dibenzo-p-dioxin and dibenzofuran.
Formation, Occurrence, and Stability of PBDDs and PBDFs
It has been recognized that the environmental presence of halogens such as bromine, and to a lesser extent iodine and fluorine, has the potential of giving rise to the formation of additional polyhalogenated dibenzo-p-dioxins and dibenzofurans (PHDDs and PHDFs) under the same conditions as PCDD and PCDF production (5) . The structural formulas of unsubstituted dibenzo-p-dioxin and dibenzofuran and the numbering ofthe carbon atoms are shown in Figure 1 . The halogenated compounds discussed in this review contain bromine (or chlorine) at the positions indicated in their names.
PBDDs and PBDFs can be produced by the pyrolysis of a variety of brominated flame retardant chemicals (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and/or flame-retarded polymeric materials. Under conditions in which a source of chlorine is also available, bromo/chloro dibenzo-pdioxins and furans are most likely produced. Because chlorinated derivatives are preferably formed during pyrolysis, fully brominated compounds will only rarely be produced, and the mixed compounds will predominate (5) . In this regard, while there are only 210 possible congeners containing a single halogen, a total of 4600 discrete bromo, chloro, and mixed halogen derivatives are possible.
Halogenated dibenzo-p-dioxins and dibenzofurans are also produced during the incineration of organic materials in the presence of halogens. The specific halogenated congeners and amounts formed depend on the reactivity of the precursors, product stability, and the Br/Cl ratios. While assuming other factors to be equal, Buser (5) computed the probable distribution of HDDs and HDFs formed during organic incineration in the presence of various Br/Cl ratios. When Br/Cl = 1, the mixed halogenated derivatives are expected to predominate, with only small amounts of products containing a single halogen (i.e., either bromine or chlorine) being formed. In the presence of a 10-fold excess of chlorine relative to bromine, the fully chlorinated compounds are likely to predominate, but mixed derivatives will still be present in small amounts.
These predictions are of practical import because Br/Cl ratios almost certainly vary from site to site. For example, in municipal incinerators, the sources ofchlorine normally far exceed sources ofbromine. Under these conditions, polychlorinated derivatives would be expected to predominate. The widespread use of brominated flame retardants in commercial products such as carpets, textiles, and plastics and their inevitable disposal, at least in part by incineration, afford a potentially significant source of bromine for the generation ofbromo and bromo/chloro dibenzop-dioxins and dibenzofurans.
The results of analyses of environmental samples are consistent with Buser's prediction of the production of mixed derivatives. The analysis of ash from municipal incinerators (18) (19) (20) (21) as well as automobile exhausts (5, 7, 22) has revealed the presence of primarily bromo/chloro dibenzo-p-dioxins and dibenzofurans.
Neupert et al. (23) examined the stability of PBDDs and PBDFs under laboratory conditions. Solutions of2,3,7,8-TBDD or TBDF in toluene were exposed to fluorescent light, at laboratory temperature, 24 hr/day for up to 6 days. Both compounds underwent degradation, with the furan appearing to degrade somewhat faster than the dioxin. After 15 days, the concentrations of the solutions had declined to less than 35 % of original. The major decomposition products were debrominated compounds containing from one to three bromine atoms. Samples of penta-, hexa-, and octa-BDDs and BDFs were similarly studied, and the rate of degradation was directly proportional to the degree ofbromination.
Buser (24) compared the photolytic decomposition ofbromo and bromo/chloro dibenzo-p-dioxins and dibenzofurans to that ofthe corresponding polychloro compounds. When dissolved in toluene, both the polybromo and bromo/chloro compounds underwent decomposition more rapidly than the corresponding polychloro derivatives. These results suggest that the brominated compounds may be less persistent than the chloro derivatives.
It should be noted, however, that environmental PBDD/Fs may be less susceptible to photodegradation than are laboratory samples. Studying the degradation of PCDDs and PCDFs adsorbed to fly ash, Koester and Hites (25) found no significant photodegradation, although the compounds are susceptible to photodegradation when dissolved in various organic solvents. These results may suggest that photodegradation may not be a significant mechanism for the removal of the chlorinated compounds from the environment and may also be less effective than anticipated in removing the bromo and bromo/chloro derivatives. Similar experiments with the brominated compounds have yet to be conducted.
Toxicity in Experimental Animals
Single-dose Studies Moore et 
Toxic Effects in Humans
Reports describing toxic effects in humans attributable to PBDDs or PBDFs were not found. However, given the similarities between the PCDDs, PCDFs, PBDDs, and PBDFs, it is reasonable to predict that the brominated compounds will produce the same spectrum ofeffects in humans as produced by the chlorinated compounds.
Despite a wide variety of toxicological manifestations exhibited by laboratory animals after exposure to the PCDDs and PCDFs, toxicological effects in humans (other than the production ofchloracne) are not well documented (1-3). Several reports suggest possible immunosuppression in humans, but these effects have not been unequivocally proven [reviewed by Lorenzen and Okey (33) ].
A common element found in nearly all pathological lesions associated with PCDDs and PCDFs is the presence of the genetically segregated Ah receptor, and the current consensus is that toxicity ofeither class ofchemicals is mediated through this receptor. Lorenzen and Okey (33) have demonstrated the presence of this receptor in cells from the human tonsil. The receptor was found to bind T1CDD and to be transformed to a nuclear binding form. Further studies on the interactions of polyhalogenated compounds with the human Ah receptor might provide useful insights into the human toxicological potential of the brominated compounds.
Developmental Toxicity in Experimental Animals
PBDDs and PBDFs are potent developmental toxins in mice. The evidence indicates that compared to chlorinated analogs, replacement ofchlorine with bromine may reduce potency somewhat, but does not appear to alter the mechanism through which this class of chemicals exerts its developmental effects (34) .
TCDD is a potent developmental toxin in mice, causing cleft palate and hydronephrosis at dose levels that produce no overt maternal or fetal toxicity (35) . Birnbaumet al. (34) studied the effect of substituting bromine for chlorine in the TCDD molecule on teratogenic potency. In addition to studying the brominated analog ofTCDD, these workers also assessed the developmental effects of TBDF, 1,2,3,7,8-penta-BDF (lPeBDF), and 2,3,4,7,8-penta-BDF (4PeBDF). Corn-oil gavage doses administered to pregnant C57BL/6N mice on gestation day 10 ranged from 0 to 192 Ag/kg (up to 0.38 jtmole/kg) for TBDD and from 0 to 4,000 jg/kg for TBDF, lPeBDF, and 4PeBDF. All doses ofeach compound significantly increased liver weights in the dams but produced no other evidence ofmaternal toxicity. TBDD and TBDF caused dose-related increases in fetal weights, and 500 jg/kg or more of TBDF significantly increased embryo/fetal mortality.
The induction of hydronephrosis was the most sensitive measure of developmental toxicity. (37) , and there is a growing body of evidence indicating that it is also carcinogenic in humans (4) . For these reasons it is prudent to assume that 2,3,7,8-TBDD is probably carcinogenic also.
Absorption, Excretion, Distribution and Metabolism
In experiments in which TBDD has been compared to TCDD, the absorption, elimination, and distribution of the two compounds appear to be similar. Although not studied simultaneously, the elimination of TBDD and TCDD appears to be similar also.
Absorption and Elimination
The studies that have been reported on TBDD to date show that, in rats, the compound is absorbed after oral, dermal, or intratracheal administration, and the primary route ofelimination is the feces, with biliary excretion appearing to be the major source of compound.
Diliberto et al. (38) studied the absorption and excretion of orally administered [3H]TBDD in male F344 rats. Doses studied included 0.001, 0.01, 0.1. or 0.5 Amole/kg. These doses are equivalent to 0.5 to 250 ,g/kg. The major route of excretion was the feces. Seventy-two hr after administration, fecal excretion accounted for 30-80% ofthe administered dose. Urinary excretion was not described. At the termination ofthe experiment, the majority of the body burden was located in liver and fat. Concentrations in these tissues for animals exposed to the two lower doses were directly related to size of the dose. Higher doses, however, were associated with a decreased percentage ofthe administered dose remaining in tissues. The dose-related increase in fecal excretion and decrease in relative tissue residues at higher doses suggest that, at the doses studied, absorption of TBDD from the gastrointestinal tract is nonlinear.
Diliberto et al. (39) reported absorption and excretion data after the administration of [3H]TBDD to male F344 rats by intratracheal instillation. Three days after the instillation (1.0 nmole/kg in 250 L ethanol: Emulphor: water), 22% ofthe administered radioactivity was found in adipose tissue and 18% was in the liver. The major route of excretion was the feces, which accounted for 37 % of the administered radioactivity within 72 hr.
Jackson et al. (40) reported that approximately 12 % of a dermally applied dose of [3H]TBDD (1.0 nmole/kg dissolved in 60 uL of acetone) was absorbed during 72 hr. Approximately 13 % of the radioactivity remained in the application site, and major tissue depots were found to be liver and adipose tissue. The liver to adipose tissue concentration ratio was 3:2. Elimination (only 17 % of the absorbed dose) was primarily via the feces. The authors stated that at equimolar doses, only 30-40% as much TBDD was absorbed through rat skin as was TCDD (40).
Kedderis et al. (41, 42) estimated that the whole/body half-life of TBDD was 2-3 weeks in F344 rats after the IV injection of 0.001 or 0.1 pmole/kg (0.5 or 50 jig/kg). By Aglkg). After the low dose, TBDD was rapidly cleared from the blood, with levels declining to less than 2 % ofthe administered dose within 1 day. Hepatic radioactivity peaked at 7 hr then declined (half-life, 17 days). Adipose tissue concentrations rose through day 14, then slowly declined (half-life, 58 days). Approximately 10% of the administered radioactivity was found in the skin at 7 hr and a biphasic elimination from this tissue resulted in a long half-life similar to that of adipose tissue (58 days). Concentrations in muscle generally paralleled those in the blood, peaking early and declining rapidly.
Although the high dose (0.1 mole/kg) was 100 times greater than the low-dose, liver concentrations were almost 700 times greater in the high-than in the low-dose groups at 56 days. These results indicate dose-related differences in deposition. In addition, the relationship between radioactivity in liver and adipose tissue exhibited both time-and dose-dependent behavior. At the low dose, liver-to-adipose-tissue concentration ratios declined from a high of 30 on day I to approximately 1 on day 14 
Mechanism of Toxicity
Based on a limited amount of testing, it appears that the PBDDs and PBDFs produce toxicty in laboratory animals that is qualitatively similar to that produced by the PCDDs and PCDFs. When in vivo exposures and in vitro concentrations of TCDD and TBDD are expressed in terms ofmicrograms, TCDD appears to be approximately twice as potent as TBDD. However, when doses and concentrations are expressed on the more appropriate molar basis, the two compounds appear to be equipotent.
Because of the similar chemical behavior of chlorinated and brominated derivatives, it seems possible that the two groups of chemicals may act through the same cytosolic receptor-mediated mechanism. Differences in potency and duration of action (if they exist) might be reflections of different rates ofmetabolism or different affinities for binding to the cytosolic receptor.
Receptor-Mediated Toxicity
There is compelling evidence that the toxic responses to TCDD and related HDDs and HDFs (including the brominated compounds) are mediated through interactions with cytosolic receptor(s), as summarized at the Banbury Conference on Dioxin (50) . It has been proposed that the toxicologic actions of the HDDs and HDFs proceed through an initial binding ofthe toxicant to a cytosolic receptor protein. Given the chemical similarities between chlorine and bromine, it is reasonable to suspect that both bromine and chlorine congeners will interact with the same receptors. However, chlorine and bromine bond strengths as well as the relative sizes of the halogen atoms differ. These factors may influence receptor binding affinities as well as the relative susceptibilities ofthe molecules to enzymatic attack and biotransformation. Under these circumstances one would expect qualitatively similar effects to be produced by chlorinated and brominated compounds, with any quantitative differences being attributable to the nature of the halogen substituent.
Although not affording unequivocal proof, the results of some recent studies on the brominated derivatives are consistent with the suggestion that the brominated and chlorinated compounds interact with the same receptors. Both brominated and chlorinated derivatives induce hepatic AHH and EROD, with the chlorinated derivatives being more potent (6, 27, 28, 30, 51) . Most recently, Birnbaum et al. (34) found that the teratogenic (cleft palate) dose-response curves for PBDDs and PBDFs in mice are parallel to those ofTCDD. The authors noted that parallel doseresponse curves may be suggestive of similar mechanisms of action.
Toxicity Equivalency Factor/TCDD Equivalent
The enormous number of polybrominated and mixed (brominated/chlorinated) dibenzo-p-dioxins and dibenzofurans makes the investigation of the toxicologic potential of even a small percentage of these compounds unrealistic. A similar dilemma exists in the case of the PCDDs and PCDFs. The toxicity equivalency factor (TEF) concept (52, 53) , which depends on a strong structure-activity relationship between the congeners and their ability to elicit a biological/toxic response in various in vitro and in vivo test systems allows the assignment of potency factors for individual members ofa chemical group. The potency factor expresses the toxicity ofa specific congener relative to that of a well-studied standard. In the case of PCDDs/PCDFs, the standard chemical is TCDD. In estimating the toxicologic potential of an environmental sample or a complex mixture, the concentration of each congener present multiplied by its equivalency factor gives the concentration of the congener in terms of the TCDD equivalent. The potential effect ofthe sample or mixture is expressed by the sum of the TCDD equivalent, as if it were concentration of TCDD itself. Safe (3) and Safe et al. (31) reviewed several classes of halogenated aromatics and suggested that the TEFs established for the PCDDs and PCDFs can be similarly used for the bromo and bromo/chloro dibenzo-pdioxins and dibenzofurans.
Comparative Potencies of PCDDs and PBDDs The in vivo effects oftwo ofthe pyrolysates on enzyme induction, body weight loss, and thymic atrophy were also determined, and TCDD equivalents were computed. The ranges of results depicted in Table 2 
Developmental Toxicity
The administration ofTBDD and TBDF to pregnant mice, at doses that cause no evidence ofmaternal toxicity, produces cleft palate and hydronephrosis in the offspring (34) . These developmental malformations are also caused by TCDD and TCDF. Although the mechanism(s) through which these chemicals produce their effects remains unknown, TCDD has been shown to potentiate the teratogenic effect of retinoic acid. It has been suggested that TCDD modulates embryonic responses to growth and differentiation factors (54) . Although TBDD has not been studied for an interaction with retinoic acid, a similar potentiation would be expected (L.S. Birnbaum, U.S. EPA, personal communication).
Skin Toxicity
The most common and persistent effect ofTCDD exposure in humans is the production of dermal toxicity [chloracne, skin hyperpigmentation, and in many victims conjunctivitis and irritation of mucous membranes (1-3)]. Pinkerton et al. (55) reported that both TBDD and TBDF were active in the dermal rabbit-ear test for acnegenic activity. However, these compounds were approximately 1000 times less potent than TCDD. It appears, therefore, that the brominated compounds have the potential to produce skin lesions in humans, although possibly at higher doses relative to those required for TCDD.
Liver Toxicity TCDD has been associated with elevated serum levels ofcertain enzymes as well as the excretion of porphoryins and hypercholesteremia. These signs are all suggestive of liver impairment. BDDs and BDFs are hepatotoxic in laboratory species. These effects are similar to those produced by polychlorinated compounds and include the induction ofenzymes and increased liver mass. These effects are not necessarily indicative of the ability of the compounds to produce hepatotoxicity in humans, but they do suggest that the liver is a potential target organ.
Gastrointestinal Effects
Human exposure to TCDD has been associated with complaints of abdominal pain, vomiting, and diarrhea. Administration ofTCDD to a few species, such as the monkey and cow, produces hyperplastic changes in the gastrointestinal tract. Such findings are not common in rodents, so it is not surprising that the studies cited in this review revealed no evidence of gastrointestinal effects associated with administration ofthe brominated compounds. Possible gastrointestinal effects due to PBDD and PBDF exposure cannot be ruled out.
Immunotoxicity TCDD and TCDF (as well as other representatives of these groups) have been repeatedly demonstrated to possess immunosuppressant activity in laboratory animals, as reviewed by Dean et al. (56) and Exon et al. (57) . Evidence of similar effects in humans, however, is less convincing. It is suspected that TCDDinduced immunosuppression may be mediated through the cytosolic Ah receptor (56) . Given the similarities between the chloro and bromo analogs, it is likely that the brominated and mixed PHDDs and PHDFs are also immunoactive compounds.
Suggestions for Future Research
Based on this review ofthe available literature on PBDDs and PBDFs, several areas for future research could provide important insights into the environmental significance and toxicological importance ofthis class of compounds. a) Improved, rapid quantitative and qualitative analytical procedures are required to better assess the magnitude of environmental contamination by the compounds. Methods should be developed for assay of fumes, water, soil, and biological samples. b) Studies of the behavior of the brominated chemicals in the ecosystem should be conducted. Such studies should be designed to determine the stability ofthe chemicals in the environment and their ability to accumulate and concentrate in the food chain. Preferential accumulation of specific congeners should be assessed. Human fat tssues should also be assayed for presence ofthe compounds. c) Because of the enormous number of mixed halogenated derivatives possible, toxicity equivalency factors should be validated for the members ofthis family ofcompounds. TEFs may also be employed to conduct structure-activity relationship studies. d) Selected bromo and mixed compounds should be assessed for genotoxic and immunotoxic potential. e) Comparative toxicology studies between bromo, chloro, and mixed dibenzo-p-dioxins and dibenzofurans should be conducted to gain insight into the role of the individual halogens in determining biological effects. These studies should include single and repeated dosage regimens and include assessments of the biological dispositions ofthe chemicals. Studies should also be designed to determine effects on reproduction and fetal development and potential carcinogenicity.
